Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia

BACKGROUND: For individuals managing diabetes, the administration of glucagon for severe hypoglycemia can be lifesaving, yet, until recently, there were no easy-to-use devices for these stressful emergencies. New products have emerged to meet this need, including nasal glucagon (NG) and auto-injecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajpai, Sanjay K, Cambron-Mellott, M Janelle, Will, Oliver, Poon, Jiat-Ling, Wang, Qianqian, Mitchell, Beth D, Peck, Eugenia Y, Babrowicz, Jane, Raibulet, Nedina K, Child, Christopher J, Beusterien, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694976/
https://www.ncbi.nlm.nih.gov/pubmed/36439296
http://dx.doi.org/10.2147/DMSO.S367010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694976/
https://www.ncbi.nlm.nih.gov/pubmed/36439296
http://dx.doi.org/10.2147/DMSO.S367010

Ejemplares similares